Introduction
Legionnaires' disease: This unscientific and clinically uninformative title arose from the historical incident that the disease first attracted the professional attention of the medical world and the emotive response of the general public when an epidemic suddenly erupted at a time (21-24 July 1976) when the American Legion, Department of Pennsylvania, was holding its 58th annual convention in Philadelphia, and 183 cases with 29 deaths (l6°.J were rapidly recorded, almost wholly associated with and related to the Legion, and affecting principally those legionnaires (total number attending convention was 4400) accommodated at and/or frequenting the lobby of the 700-roomed seventy-year-old Bellevue-Stratford Hotel.
Broad Street pneumonia: The same syndrome as Legionnaires' disease (LD) was observed during the period (I July-IS August) in 39 other persons who were not so closely associated with the hotel, who in fact did not enter the hotel building during the epidemic period but who were within one block distance of the hotel in Broad Street. The title of Broad Street pneumonia was given to this disease. Legionnaires' disease and Broad Street pneumonia greatly alarmed the citizens of Philadelphia and resulted in a sharp drop of visitors to the city.
Europe: We in the UK were first alerted in 1977 to the presence of the disease on this side of the Atlantic by a joint Scottish-Spanish investigation which by retrospective studies threw up the fact that as far back as 1973 a group of holiday-makers from Scotland on a package tour to Benidorm on the Spanish Costa Blanca experienced considerable morbidity from a respiratory illness, with 3 deaths in a party of 252 staying at one hotel.
The story began dramatically enough, when on 24 July 1973 a holiday-maker from Benidorm, returning back to Scotland, became severely ill on the plane and was found dead on arrival at Glasgow Airport. The first indigenous case to be reported in UK was also from Scotland, when a 21-year-old woman was admitted to hospital on 3 May 1976 and diagnosed as suffering from pneumonia and right-sided pleurisy; unfortunately this was another fatality, despite treatment with streptomycin, penicillin, isoniazid, erythromycin, gentamicin and metronidazole. In England a cluster of patients with likely signs and symptoms admitted to the City Hospital, Nottingham, in August and September 1977 were investigated and proved to be suffering from LD.
In London our attention was drawn to the occurrence of cases in the capital when a 45-yearold Scottish man was admitted to St Stephen's Hospital on 10 November 1977 with severe bilateral pneumonia; he died 3 days later despite treatment with penicillin, flucloxacillin, ampicillin, gentamicin, metronidazole and erythromycin; it is very likely that alcoholism and ischaemic heart disease contributed to the fatal outcome. Another patient was a 58-year-old housewife admitted to Charing Cross Hospital on II November 1977 who was treated successfully with erythromycin when her medical attendants resorted to an open lung biopsy, in a final coup-de maitre gesture in an effort to diagnose her condition, and histological sections revealed the organism of LD.
Distribution
Originally reported from Philadelphia, Pennsylvania the disease has been found in many states of the USA, thus pointing to the wide distribution of this infection previously completely undiagnosed. The disease has been detected in recent months in Canada, Scotland, England, Spain and Italy.
By retrospective diagnosis on clinical and serologic grounds other episodes of LD have come to light, such as that (Pontiac fever) affecting officials and visitors to the Public Health Department Building in Pontiac, Michigan, in July 1968. This was a mild and untypical epidemic. The disease had a very short incubation period of 1-2 days, then signs and symptoms began with an acute onset of fever, chills and myalgia lasting 2-4 days with minor respiratory symptoms; pneumonia was not seen, in marked contrast to LD. There were 144 patients, with no deaths.
Not so fortunate were the inmates of the St Elizabeth's Psychiatric Hospital, Washington DC, when in 1966 an epidemic attacked 94 patients, and caused 16 deaths.
It is strongly felt that an outbreak of LD occurred in Philadelphia in 1974, in the same Bellevue-Stratford Hotel following a convention.
The infectious agent
Such an episode as LD breaking out in the USA, a country with so much expertise, professional know-how and sophisticated laboratory equipment, could not but attract an immediate and all-out effort to determine the cause and thus halt the outbreak. This was the period of the swine influenza alert in the USA, and in the first instance the disease was tackled from this aspect; but histological findings in lungs from fatal cases showed it to be more like an acute bacterial pneumonia than a viral pneumonitis.
Despite a multidisciplinary attack by many experts no organism was isolated and this negative result seemed to eliminate bacteria, chlamydiae, fungi, mycoplasmas, rickettsiae and viruses. No microbial agent was detected by electron microscopic examination of lung tissue. Bacterial and yeast cultures of lung tissue, faecal and oral specimens showed only normal microbial flora. Attempts to isolate viruses by inoculation into eggs (via the amniotic, allantoic, yolk sac routes) or inoculation of Rhesus monkey kidney cells, Vero monkey kidney cells, human embryonic lung fibroblasts, human embryonic kidney cells and rhabdosarcorna cells all proved negative.
Sera from patients were tested against 77 known infective agents with no definite positive results.
Attention was then given to chemical metallic toxic agents, toxic gases and organic toxic agents, still with no success; metals tested were mercury, arsenic, antimony, cobalt, cadmium, zinc, copper, iron, silver, tungsten, thallium, gold, osmium, chromium, selenium, molybdenum, thorium, tin, beryllium and nickel. An excessive amount of nickel was indeed reported from the lungs (but not from other tissues) of fatal cases, when more than 9 times the normal amount compared to controls was found; this. however, was either due to faulty collection or related to occupation and environment of the patient. Another possibility which was investigated, only to be excluded, was paraquat poisoning, which can produce pulmonary disease on ingestion; but no paraquat was detected in the patients' tissues (lungs) or excretions (urine).
The real aetiological agent was finally run to earth when some weeks later, during a review of the supposedly negative specimens, tiny red particles, which had been missed or disregarded before, were seen in histological sections of tissues of guinea-pigs inoculated with suspensions of specimens from patients.
Lung tissue from a fatal case of LD and from a fatal case of Broad Street pneumonia were inoculated into 6 guinea-pigs; 4 of them developed fever, watery eyes and prostration 48 hours after inoculation. Suspensions of guinea-pig organs (spleens) were in turn subcultured on to usual bacterial media with negative results, and also into yolk sacs of fertile hens' eggs from antibiotic-free chicken flocks, this procedure proving fatal to the embryos after 4-6 days. Smears were then prepared from these infected yolk sacs and stained by a special stain (Gimenez carboI fuchsin-malachite green stain). Examination of these stained smears then revealed the answer to the problem of LD: rod-shaped pleomorphic bacilli. That the organism was no adventitious agent was proved conclusively when sensitive and specific immunofluorescent tests utilizing convalescent sera from infected guinea-pigs and human patients gave a positive and specific result, thus proving the newly detected bacterium to be the causative agent of Legionnaires' disease.
In December 1976 the same organism was successfully isolated directly in vitro from the pleural fluid of a 39-year-old female patient, in Flint, Michigan, by culturing on a commercially available chocolate agar with suitable added enrichments. Some of the characteristics of the new organism are:
(1) Gram-negative bacterium, 0.5-0. 7 urn in diameter and 2-3 urn long, though it can produce rods up to 20 urn in length. The long forms are commonly curved; bacterial bodies are also seen.
which have a vacuolated ap,pearance, and these areas stain with Sudan Black B stain.
(2) It can be isolated in vivo in guinea-pigs by intraperitoneal inoculation of infected specimens, and in the yolk sac of the embryonated hens' eggs.
(3) It can be grown in vitro only in specially enriched bacteriological culture media such as the Mueller-Hinton agar (commonly used for antibiotic susceptibility tests) enriched with I~h aemoglobin solution or 5°o Fildes' peptic digest of sheep blood, and 2°~IsoVitaleX (Baltimore Bacteriological Laboratories). The media should be standardized at pH 6.9 to 7.0. Growth also occurs in Mueller-Hinton broth supplemented with Fildes' enrichment medium (3-4';;') and IsoVitaleX. (4) The bacterium is aerobic and grows best in an atmosphere containing 2.5-5% carbon dioxide. It does not grow under anaerobic conditions. (5) The optimal temperature for growth in vitro is 35°C, though slight growth occurs at 30°C. It does not grow at 42°C or at 25°C. On first culture it takes some time to grow; hence cultures should be incubated for up to 10 days before being discarded as negative. On subsequent subcultures marked growth occurs in 3-4 days. (6) Two kinds of colonies are produced: a 'dwarf' colony; and another much larger, up to 2 mm diameter. (7) Action on carbohydrates (commonly known in laboratory parlance as sugars): these reactions, which are such a feature of laboratory reports in connection with the more familiar organisms, have not yet been investigated, no doubt owing to the difficulty in culturing this bacterium in vitro. (8) Biochemical characteristics: the organism gives positive gelatin, starch, catalase and oxidase tests. It gives a negative urea and nitrate test. (9) Important differential characteristics: a singular feature of this new organism is the presence of large amounts (81-90~:,) of branched-chain fatty acids, which in general arc characteristic of gram-positive bacteria, coupled with absence of other common acids generally found in gram-negative bacilli. This feature will obviously form a basis for future taxonomic purposes, for the bacterium appears to have a unique characteristic fatty acid profile, at least under the conditions so far studied in the laboratory. (10 Variants: the mild outbreak at Pontiac, which clinically differed so much from the Legionnaires' disease seen in Philadelphia, may suggest that there could be variant strains of this organism or perhaps even very closely related species.
Epidemiology
From studies undertaken so far the evidence seems to suggest that person-to-person transmission is not likely, if it occurs at all.
The hotel room-mates of the legionnaires affected in the Philadelphia outbreak did not sutTer more infections than carefully investigated peer control groups. Patients did not appear to transmit the disease to members of their own household or to their friends. Many of those affected were going-on in years, with a mean age of 55-56 years. There is also an association with debilitating conditions: those whose health is below par are more liable to the more virulent form of LD; sixty-eight of those affected in Philadelphia in 1976 were known to have had significant pre-existing illness, such as cardiopulmonary disease, diabetes mellitus and malignancy. The case fatality ratio for those with debilitating conditions was 29'/0' as against 5'/0 for the others who were not so compromised.
If LD was as communicable as influenza, measles or chickenpox we would have discovered the organism long before 1976. It appears to be an airborne infection. At the moment of writing a hotel workman employed in changing air-conditioning filters in London is thought to have LD, and similarly the air-conditioning mechanism repair man at the Bellevue-Stratford Hotel showed clinical signs and symptoms at the time of the 1976 Philadelphia epidemic. And in the Pontiac (1968) and Washington (1966) outbreaks nearby excavation activities were supposed to be associated factors.
The unsolved questions with regard to this bacterium are: Where is its habitat? Is there a reservoir host, perhaps a silent one? Is there a vector?
On retrospective serologic investigation into the Philadelphia outbreak it was discovered that 29% of the employees at the Bellevue-Stratford Hotel had evidence of antibodies against the LD bacterium, especially staff members employed before 1975.
The fact that the organism does not grow in the laboratory at room temperature, and grows optimally at 35°C, may point to some animal host-reservoir, perhaps a rodent or a bird; from these hosts airborne infection by aerosols could occur. Or perhaps an insect vector may be involved though this does not at present seem at all likely.
Extensive investigations on other possible routes, such as food and restaurants, have been ruled out. A water-borne route of transmission was under suspicion, but the most likely at the present moment is thought to be the airborne route.
The morphological, cultural and epidemiological characteristics of the organism are somewhat similar to the rickettsial organism, Rickettsia akari, which causes rickettsial pox. This disease has been found among residents of apartment houses where the infected house mouse (Mus musculus) infests the refuse shutes; its infected ectoparasite vector mite (Allodermanyssus sanquineusv, in which transovarian transmission of the rickettsial parasite occurs from one generation to another, and the rickettsial organisms maintain a natural menage-a-trois cycle of infection in a world of their own.
Is there a domestic pest or vermin acting similarly as a reservoir, perhaps also similarly infested with some ectoparasite, and both infected with the LD bacterium and maintaining a similar cycle in the comfortable and secure service channels of our multi-storeyed hotels, hospitals and other public buildings? A hospital investigation team in Kingsport, Tennessee, resorted to the stratagem of placing sentinel guinea-pigs, which as stated above are susceptible to LD bacterium, within the hospital compound and in 7 homes in the neighbourhood. No success has to my knowledge been reported. Rats and other small mammals were also trapped and investigated.
On the other hand, it is interesting to record that a positive culture of the LD bacterium was obtained from a guinea-pig (lung tissue) that had been exposed to the environment of the Public Health Department at Pontiac, Michigan, during the outbreak of the respiratory illness in 1968, and which had been kept frozen at -70°C since then. The disease has obviously been present for many years in many countries. The risk is stated to be higher in heavy smokers, but this is a feature associated with many other pulmonary infections and hence not specifically with LD.
Pathology
From the post-mortem examinations of the unfortunate victims who have succumbed to the disease it is observed that the characteristic findings of this newly described entity are largely limited to the lungs. In these organs the classical and familiar changes of pneumonia are seen. The essential feature in histological diagnosis is the specific finding of the LD bacterium, which can be detected by electron microscopy and by special silver impregnation (Dieterle's) methods or by the specific and sensitive methods of immunofluorescent antibody staining. The LD organisms will be seen both extracellularly and also intracellularly in the inflammatory cellular infiltration; they are most numerous in the necrotic debris in affected alveoli and respiratory bronchioles, and only rarely seen in bronchi, larger bronchioles or alveolar septa. The cells comprising the cellular infiltration are polymorphonuclear neutrophils and macrophages. The Gimenez stain mentioned in previous paragraphs can also be used to detect the bacilli.
Liver: This organ may show centrilobular fatty change.
Kidney: The pathological features seen in the kidneys may vary from no readily detectable changes to advanced tubular degeneration and necrosis.
Signs and Symptoms
The incubation period is short, 2-10 days. The early signs and symptoms consist of malaise, body aches, a rapidly rising hectic fever (up to 102-105°F, 39-41°C), chest pains and chills. Upper respiratory signs are not found. A dry nonproductive cough with dyspnoea then sets in, and the cough later becomes productive but not usually purulent. Gastrointestinal symptoms, with in some cases bleeding manifestations, accompany these clinical events. A fatal termination is heralded with the onset of respiratory failures, renal failure or shock.
Chest radiographs show patchy infiltrates at first, later progressing to areas ofconsolidation. Pleurisy may be present in some cases.
As with other uncommon diseases, a clinical awareness of the existence and possibility of occurrence of this disease is essential; and LD should be considered as a possible diagnosis when (a) a patient suffers from an 'unusual' pneumonia; (b) it is rapidly progressing; (c) it does not respond as usual to a chemotherapeutic regime; (d) the laboratory reports normal flora only; (e) the patient shows signs of confusion, disorientation or bizarre behaviour. Patients Who are elderly and/or debilitated, from whatsoever cause, fare badly when affected by this disease.
Defervescence in favourable cases is by lysis. The patient can look forward to complete recovery though radiographic evidence of resolution of the pathological process lags a few days behind clinical improvement.
Diagnosis
Now that we have discovered the cause of this disease, and the organism has been isolated and cultured in the laboratory, the confirmatory laboratory diagnosis of LD has become conveniently available to support a clinical suspicion of this bacterial pneumonia.
Serology: Tests done on paired sera are at the moment the methods of choice. The clinician should note that antibodies in this disease appear and develop slowly, so that while antibodies can be detected as early as the second week after infection the diagnostic rise in titre will be expected later (from 3 weeks to 2 months).
(1) An immunofluorescent (indirect fluorescent antibody test: IFAT) technique is used: (a) Slides are prepared by placing drops of the specific bacterial antigen. (b) Doubling dilutions of the patient's serum are then dropped on this dried and fixed bacterial antigen. The preparation is incubated for 30 min at 37°C and then rinsed. (c) Finally diagnostic anti-human globulin reagent, conjugated with a fluorescent dye, is dropped in turn on above. The preparation is again incubated and rinsed. (d) The slide is now ready for examination by ultraviolet-light microscope.
(2) Other serologic tests such as the complement fixation test (CFT) and agglutination tests are under investigation but so far have not proved as sensitive or as specific as the IFAT.
(3) IFAT screening tests are conveniently done at a serum dilution of 1/64. Positive serologic tests demand the usual four-fold rise in titre or a single serum titre in excess of 1/128. The clinician, however, will exercise his judgment when suggestive clinical signs and symptoms are associated with a titre not exceeding 1/128.
Isolation ofbacterium: detection ofantigen
(1) Primary isolation of the organism can be attempted in vitro on specially enriched media (see p 363) from specimens such as sputum, tracheal aspirations, bronchial washings, pleural fluid and tissues such as lung tissues taken before or after death.
(2) Primary isolation of the organism is also attempted in vivo. Preparations of the above pathologic specimens are inoculated (1 ml amounts) intraperitoneally into guinea-pigs and these laboratory animals are then kept under observation for 10 days and watched for signs of infection, fever, prostration, weeping eyes. The presence of the bacterium can be detected by staining smears prepared from the organs (spleen) of the sick guinea-pigs or peritoneal cells; suspensions of organs are also subcultured into yolk sacs of fertile hens' eggs and yolk sac preparations are then stained by Gimenez stain, as in the original work leading to the discovery of this organism.
(3) Lung tissues taken before or removed after death of a patient can be stained specifically by immunofluorescent technique; this is a most useful method. Histological section can also be stained by a silver impregnation procedure (Dieterle's) used for demonstrating delicate spirochaetes in tissues. This method will demonstrate the characteristic bacterium, i.e. small blunt or pleomorphic rods, stained brownish-black on a yellow background. The usual routine haematoxylin and eosin (H & E) stain will not detect the bacterium, which is probably the main reason why this pathogenic organism has been missed before now in lung tissue sections from pneumonia cases. The Gimenez stain can also be utilized for frozen sections of fresh or even formalin-fixed lung sections, but it is not recommended for paraffinized tissue sections. However, it is said that paraffinized sections, even when already stained by H & E, can be decolorized and restained with Dieterle's method; thus a retrospective diagnosis may still be possible on slides stored in histologic filing cabinets! (4) Electron-microscopy may prove of some use in the detection of the bacterium, and may prove even more useful when immuno-electron-microscopy is adapted for direct and specific detection of the LD organism.
Nonspecific tests: The fol1owing show an increase: (a) white blood cell count, a moderate increase with a shift to the left; (b) erythrocyte sedimentation rate; (c) proteins in the urine; (d) blood urea; (e) the enzymes alkaline phosphatase and serum glutamic oxaloacetic transaminase. The plasma sodium is diminished.
Other observations: At the moment of writing it is now possible to refer specimens to Dr R J Fallon (Glasgow). When this paper appears in print it is probable that all PHLS laboratories in England and Wales will be in a position to investigate outbreaks of LD and test individual specimens from sporadic cases, since a local home-grown antigen has now been prepared both in Sotland and in England (personal communications 1978, from Dr R J Fallon and Sir Robert Williams).
It is to be hoped that in both instances the local product will work as effectively as that in use at the Centre for Disease Control, Atlanta, where specimens have hitherto had to be referred.
Treatment
In future we expect our bacteriological laboratories to isolate successfully the LD bacterium from specimens referred to them and no doubt a report on the susceptibility of the organism to antibiotics and other chemotherapeutic drugs will be forthcoming.
However, it is just as well to keep in mind that results obtained by in vitro methods in the laboratory may not be always strictly and safely extrapolated to the expected effects of the drug of choice in the human body.
The bacterium in vitro can be shown to be susceptible to erythromycin, cephalosporins, aminoglycosides, rifampin, and trimethoprim-sulphamethoxazole; when the organism is tested in the embryonated eggs its growth is affected by rifampin, gentarnycin, streptomycin and erythromycin.
Specific treatment: (a) From studies of hospital charts of patients, in vitro determinations of antimicrobial susceptibility tests, and in vivo determinations in guinea-pigs and embryonated eggs, erythromycin has emerged as an effective drug against the LD bacillus. (b) Doxycycline (Vibramycin, a tetracycline derivative) has been used successfully in one patient.
Immunoprophylaxis
Once we have the agent growing in abundance in pure cultures there is always the feasibility of preparing a vaccine. Is there, for example, a need to protect the research workers and laboratory staff who may be expected to be exposed to an artifically high concentration of the organism in their laboratories? And will there be a need to protect certain selected groups of patients, namely the debilitated, the elderly and the immunosuppressed?
